CVS Health stock trades 14.74 percent below its 52-week high

Published on 10/27/2026 at 16:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

A USD 107.80 consensus target was cited October 19, 2026. CVS Health stock costs EUR 82.63 on October 27, 2026, down 0.21 percent versus Xetra close.

Price position and upcoming results

CVS Health stock stood 14.74 percent below its EUR 96.90 52-week high on October 27, 2026.
The consensus target was USD 107.80 on October 19, 2026.
CVS Health stock cost EUR 82.63 at Lang & Schwarz on October 27, 2026 at 4:41 p.m. CEST, down 0.21 percent versus the October 26, 2026 Xetra close.
CVS Health is scheduled to discuss third-quarter 2026 results on November 4, 2026.

CVS Health Corp., US1266501006, Illustration mit AI erstellt.

CVS Health Corp. (ISIN US1266501006) stock stood 14.74 percent below its 52-week high of EUR 96.90 on October 27, 2026. The comparison places the share below its recent peak while leaving the daily move nearly unchanged. At Lang & Schwarz on October 27, 2026 at 4:41 p.m. CEST, the stock was trading at EUR 82.63, down 0.21 percent versus the Xetra close of October 26, 2026 at EUR 82.80.

Consensus target stays above the quote

MarketBeat reported on October 19, 2026 that CVS Health carried a Moderate Buy consensus and an average target of USD 107.80, based on 20 Buy ratings and three Holds. The target is a separate US dollar valuation reference and is not combined with the euro quotation.

The latest reported operating figures came from the second quarter ended June 30, 2026. According to Ticker Scout, revenue rose 7.30 percent year over year to USD 106.10 billion, while adjusted earnings per share reached USD 2.58 versus USD 1.81 a year earlier. GAAP diluted earnings per share were USD 2.31, compared with USD 0.80 in the second quarter of 2025.

Range leaves room below the high

The 52-week euro range was EUR 59.71 to EUR 96.90 as of October 27, 2026. At EUR 82.63, CVS Health sat EUR 14.27 below the high, a 14.74 percent gap calculated in the same currency. The euro market capitalization was EUR 106.1 billion on that date.

What comes on November 4?

CVS Health has scheduled its third-quarter 2026 results for November 4, 2026. The company said in its investor-relations announcement that the conference call will begin at 8:00 a.m. ET and will discuss the quarter's financial results, giving investors a defined near-term date for the next operating update.

The second-quarter comparison showed a 7.30 percent revenue increase and a USD 0.77 improvement in adjusted earnings per share over the prior-year quarter. The next report will indicate whether that improvement continued into the third quarter.

Stock position in perspective

CVS Health combines health insurance, pharmacy services, retail pharmacies and prescription drug coverage. Its second-quarter revenue of USD 106.10 billion provides a scale marker for the business, while the 14.74 percent distance from the euro 52-week high keeps the price position central to the market view.

CVS Health was trading at EUR 82.63 at Lang & Schwarz on October 27, 2026 at 4:41 p.m. CEST, down 0.21 percent versus the Xetra close of October 26, 2026 at EUR 82.80. The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.